News
This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Sterol 14 Alpha-Demethylase Inhibitor development. The report ...
Mosaic Therapeutics a UK-based oncology company has announced ... He added: “The in licensing of these two clinical-stage assets provides a step change in our development pipeline allowing Mosaic to ...
Endlyz Therapeutics has launched from stealth, unveiling its pipeline of small molecule modulators designed to restore lysosomal function in Parkinson’s disease (PD) and other neurodegenerative ...
The investment will support further development of the Company’s growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader ...
Eikon Therapeutics has secured $350.7 million in Series D financing to advance its clinical stage programs and expand its pipeline. The latest funding round brings the company’s total private funding ...
It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type.
The acquisition of Nimble Therapeutics by AbbVie is poised to benefit both. AbbVie will gain a valuable addition to its pipeline, enhancing its established expertise in immunology with Nimble's ...
The latest update is out from Foghorn Therapeutics ( (FHTX ... Foghorn is well-equipped to advance its pipeline into 2027, aiming to transform treatments for a variety of cancers.
Mayank Mamtani has given his Buy rating due to a combination of factors surrounding Denali Therapeutics’ solid financial position and promising developments in their pipeline. The company’s ...
CRISPR Therapeutics CRSP reported third-quarter results in line with our expectations, and its pipeline candidates are continuing to make progress. We maintain our positive outlook and fair value ...
SAN DIEGO--(BUSINESS WIRE)--Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today participation in the following upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results